Incidence of Acute Kidney Injury in Patients Coinfected with HIV and Hepatitis C Virus Receiving Tenofovir Disoproxil Fumarate and Ledipasvir/Sofosbuvir in a Real-World, Urban, Ryan White Clinic-Reference-Cited by-同舟云学术

Incidence of Acute Kidney Injury in Patients Coinfected with HIV and Hepatitis C Virus Receiving Tenofovir Disoproxil Fumarate and Ledipasvir/Sofosbuvir in a Real-World, Urban, Ryan White Clinic

Published:2018-08 Issue:8 Volume:34 Page:690-698
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Michal Jessica L.¹,Rab Saira²,Patel Manish²,Kyle Alison W.³,Miller Lesley S.⁴,Easley Kirk A.⁵,Kalapila Aley G.⁶

Affiliation:

1. Department of Pharmacy Service, McLeod Regional Medical Center, Florence, South Carolina.

2. Department of Pharmacy and Drug Information, Grady Health System, Atlanta, Georgia.

3. Grady Infectious Disease Program, Atlanta, Georgia.

4. Department of Medicine, Division of General Medicine and Geriatrics, Emory University School of Medicine, Atlanta, Georgia.

5. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, Georgia.

6. Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2017.0271

Reference40 articles.

1. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

2. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

3. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

4. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

5. Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study;Journal of Microbiology, Immunology and Infection;2023-08

2. Acute Kidney Injury in Human Immunodeficiency Virus, Tuberculosis, and Human Immunodeficiency Virus/Tuberculosis Patients on Treatment and its Association with Host Predicting Factors, in South-West Region of Cameroon;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2023-04

3. Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury;Molecules;2021-09-30

4. Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy;Journal of Viral Hepatitis;2021-04-03

5. Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury;Molecules;2020-12-07